Fight Colorectal Cancer shared a post on LinkedIn:
“Colon cancer is on the rise—but so is progress.
With nearly 20 approved drugs and dozens of new immuno-oncology and cellular therapies in the pipeline, colorectal cancer research is accelerating.
Fight CRC Board Member Dr. Richard Goldberg urges regulatory innovation to keep pace with scientific breakthroughs.
Read his guest editorial in The Cancer Letter: Regulation Must Keep Up with Scientific Advances.”
More posts featuring Colorectal Cancer.